Ligand Pharmaceuticals
LGND
#3617
Rank
C$5.14 B
Marketcap
C$261.51
Share price
-1.57%
Change (1 day)
52.46%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2025 (TTM): C$88.66 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are C$0.25 Billion. In 2024 the company made an earning of C$7.55 Million a decrease over its 2023 earnings that were of C$87.55 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$88.66 M1073.39%
2024 C$7.55 M-91.37%
2023 C$87.55 M-7.59%
2022 C$94.74 M4%
2021 C$91.1 M296.42%
2020 C$22.98 M-97.97%
2019 C$1.13 B275.62%
2018 C$0.30 B237.48%
2017 C$89.38 M49.05%
2016 C$59.97 M55.41%
2015 C$38.58 M36.87%
2014 C$28.19 M29.59%
2013 C$21.75 M1309.35%
2012 C$1.54 M-43.97%
2011 C$2.75 M-113.19%
2010 -C$20.89 Million59.86%
2009 -C$13.07 Million-61.33%
2008 -C$33.8 Million-58.75%
2007 -C$81.92 Million20.52%
2006 -C$67.97 Million81.27%
2005 -C$37.5 Million
2003 -C$26.11 Million-20.6%
2002 -C$32.88 Million4.38%
2001 -C$31.5 Million-48.83%
2000 -C$61.55 Million-19.74%
1999 -C$76.69 Million-19.06%
1998 -C$94.75 Million126.71%
1997 -C$41.8 Million-5.83%
1996 -C$44.38 Million136.23%
1995 -C$18.79 Million-33.97%
1994 -C$28.46 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$44.10 B 48,402.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.13 B 17,644.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$30.63 B 33,591.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
C$11.22 B 12,242.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-C$0.37 Billion-504.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
C$31.43 B 34,469.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$10.93 B 11,926.71%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
C$12.69 B 13,857.90%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-C$84.24 Million-192.65%๐Ÿ‡บ๐Ÿ‡ธ USA